CPHI Milan · 6–8 October 2026Plan a conversation

SIKALIAS · KNOWLEDGE IN PRACTICE

Scientific projects & development

Stasinos Chr. Sikalias: Greek Formulary Sikalias and EIREN/Firmie cosmetic development projects.

Greek Formulary Sikalias

Collection and documentation of compounded preparations, edited by Stasinos Chr. Sikalias. The project connects source review with search tools, arithmetic formula scaling and controlled laboratory records.

Search & read

261 individual bilingual monographs. Search by ingredient, title or dosage form and open the relevant record.

Search the formulary

Formula scaling

Arithmetic scaling where the source batch basis is explicit. It preserves q.s. and does not convert mass to volume, set patient doses or establish beyond-use dates.

Methodology & limits

SOPs & records

32 SOPs and 18 blank forms supporting documentation, checks and adaptation to the local laboratory.

Quality system

Evidence decisions

Of 19 special cases, 5 have a reconciled basis and 4 are restricted to fresh intermediates within the same operation. The remaining 10 require actual supplier or laboratory evidence.

Review closure criteria

From a scientific question to product development

As President, CEO & R&D Manager of Sikalias Pharmaceutical Laboratories, Stasinos Chr. Sikalias connects product strategy with development planning and coordination. EIREN and Firmie are being developed by Sikalias Pharmaceutical Laboratories. They are not yet available for sale and no launch date has been announced.

EIREN

Baby care with short formulas and ingredients also used in foods, assessed for their cosmetic application. External-use cosmetics, not products to ingest.

Explore EIREN

Firmie

Facial serum development: FIRM 5 as the core step and NIGHT 0.1 as an optional evening product. Published ingredient research guides design; finished-product performance requires its own testing.

Explore Firmie
Collaborate on development ↗